Can a single ketamine infusion rewrite the story of fibromyalgia pain?
NCT ID NCT06916403
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This trial tests whether slow intravenous ketamine infusions can safely reduce pain in people with fibromyalgia. Researchers will measure pain levels before and after treatment, and track how long any relief lasts. They will also look for traits that predict who responds best, aiming to personalize future treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ketamine given as an intravenous infusion
- What this could lead to
- If effective, ketamine infusions could offer a new option for managing fibromyalgia pain, potentially providing longer-lasting relief than current treatments.
- What could go wrong
- This is a small, early-stage trial. Ketamine can cause dissociative side effects, and pain relief may be short-lived or not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wilderman Medical Clinic
Thornhill, Ontario, L4J 1W3, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could hidden sleep problems be worsening fibromyalgia?
- Can a nerve zap in the neck tame fibromyalgia pain?
- Could a simple mineral calm the stress of fibromyalgia?
- Unlocking the genetic roots of fibromyalgia's pain puzzle
- Could a probiotic soothe fibromyalgia pain in young people?
- Coloring away pain? a trial tests mandala art for fibromyalgia relief